Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6NCya-Tsga10em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6NCya-Tsga10em1/Cya

Common Name
Tsga10-KO
Product ID
S-KO-04793
Backgroud
C57BL/6NCya
Strain ID
KOCMP-211484-Tsga10-B6N-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Tsga10-KO Mouse (Catalog S-KO-04793) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Tsga10-KO
Strain ID
KOCMP-211484-Tsga10-B6N-VA
Gene Name
Tsga10
Product ID
S-KO-04793
Gene Alias
Gm217, Mtsga10, 4933432N21Rik
Background
C57BL/6NCya
Gene Full Name
testis specific 10
Modification
Conventional knockout
NCBI ID
211484 (Mouse)
Phenotype
MGI:2685063
Chromosome
Chr 1 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000041815
NCBI Transcript ID
NM_207228
Target Region
Exon 6~9
Size of Effective Region
~6.5 kb
Overview of Gene Research
Tsga10, or testis-specific gene antigen 10, is a testis-specific protein highly conserved among species. It is involved in crucial biological functions, with its role in spermatogenesis and cancer-related processes being of particular interest. In spermatogenesis, it may be associated with the autophagy pathway, and in cancer, it has implications in signaling pathways related to carcinogenesis [1,5].

In mice, Tsga10 deficiency created by CRISPR/Cas9 technology led to male infertility in heterozygous Tsga10 male mice. The infertility was due to significantly reduced sperm motility caused by disordered mitochondrial sheath formation. Also, a homozygous deletion within Tsga10 in a human patient with acephalic spermatozoa was identified, suggesting its importance in sperm structure [3,6]. In cancer research, overexpression of Tsga10 in HeLa cells disrupted the hypoxia-inducible factor-1α (HIF-1α) axis. In human umbilical vein endothelial cells (HUVECs), Tsga10 overexpression decreased cell proliferation, migration, and in vitro angiogenesis. In breast cancer cells, Tsga10 overexpression decreased metastatic and metabolic activity by inhibiting HIF-1 [2,4].

In conclusion, Tsga10 is essential for male fertility, specifically in the arrangement of the mitochondrial sheath in spermatozoa. In the context of cancer, it shows potential as a target for anti-cancer therapies, as its overexpression can suppress tumor progression by inhibiting processes like angiogenesis, metastasis, and cancer cell metabolism. The study of Tsga10 using gene knockout models in mice has provided valuable insights into its functions in both spermatogenesis and cancer-related biological processes [1-6].

References:
1. Taghizadeh-Hesary, Farzad, Ghadyani, Mobina, Kashanchi, Fatah, Behnam, Babak. 2024. Exploring TSGA10 Function: A Crosstalk or Controlling Mechanism in the Signaling Pathway of Carcinogenesis? In Cancers, 16, . doi:10.3390/cancers16173044. https://pubmed.ncbi.nlm.nih.gov/39272902/
2. Amoorahim, Mahtab, Valipour, Elahe, Hoseinkhani, Zohreh, Moradi, Sajad, Mansouri, Kamran. 2019. TSGA10 overexpression inhibits angiogenesis of HUVECs: A HIF-2α biased perspective. In Microvascular research, 128, 103952. doi:10.1016/j.mvr.2019.103952. https://pubmed.ncbi.nlm.nih.gov/31704243/
3. Luo, Geng, Hou, Meiqi, Wang, Bo, Wang, Jiarui, Zhang, Xianqin. 2020. Tsga10 is essential for arrangement of mitochondrial sheath and male fertility in mice. In Andrology, 9, 368-375. doi:10.1111/andr.12889. https://pubmed.ncbi.nlm.nih.gov/32790169/
4. Jahani, Mozhgan, Shahlaei, Mohsen, Norooznezhad, Fatemeh, Mahnam, Azadeh, Mansouri, Kamran. 2020. TSGA10 Over Expression Decreases Metastasic and Metabolic Activity by Inhibiting HIF-1 in Breast Cancer Cells. In Archives of medical research, 51, 41-53. doi:10.1016/j.arcmed.2019.12.002. https://pubmed.ncbi.nlm.nih.gov/32086108/
5. Asgari, Rezvan, Bakhtiari, Mitra, Rezazadeh, Davood, Esmaeili, Farzaneh, Mansouri, Kamran. 2021. TSGA10 as a Potential Key Factor in the Process of Spermatid Differentiation/Maturation: Deciphering Its Association with Autophagy Pathway. In Reproductive sciences (Thousand Oaks, Calif.), 28, 3228-3240. doi:10.1007/s43032-021-00648-6. https://pubmed.ncbi.nlm.nih.gov/34232471/
6. Sha, Y-W, Sha, Y-K, Ji, Z-Y, Xu, X, Li, L. 2018. TSGA10 is a novel candidate gene associated with acephalic spermatozoa. In Clinical genetics, 93, 776-783. doi:10.1111/cge.13140. https://pubmed.ncbi.nlm.nih.gov/28905369/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research